Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: A prospective case-control study
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease across the spectrum of hypothyroidismJournal of HepatologyVol. 57Issue 1PreviewThe aim of this study was to characterize the relationship between the broad spectrum of hypothyroidism and NAFLD. Full-Text PDF We read with great interest the article by Chung et al. [[1]Chung G.E. Kim D. Kim W. Yim J.Y. Park M.J. Kim Y.J. et al.Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.J Hepatol. 2012; 57: 150-156Abstract Full Text Full Text PDF PubMed Scopus (205) Google Scholar] showing that subclinical hypothyroidism, even in the range of upper normal thyroid stimulating hormone (TSH) levels, was closely associated with non-alcoholic fatty liver disease (NAFLD) in a dose-dependent manner. Their results indeed provided important evidence, confirming the close relationship between these two diseases. However, as mentioned by the authors, the causal relationship between hypothyroidism and NAFLD could not be identified by their cross-sectional study. Recently, we have performed a prospective case-control study to evaluate the impact of subclinical hypothyroidism on the development of NAFLD in a Chinese population. The study was conducted among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China, since 2006. The study population was described in detail in our previous studies [2Xu C. Yu C. Xu L. Miao M. Li Y. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study.PLoS One. 2010; 5: e11578Crossref PubMed Scopus (124) Google Scholar, 3Yu C. Xu C. Xu L. Yu J. Miao M. Li Y. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholicfatty liver disease.J Hepatol. 2012; 56: 241-247Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar]. A total of 327 subclinical hypothyroidism subjects were enrolled. Age, gender, and body mass index (BMI) are three major factors that may influence the development of NAFLD. To reduce the influence of these variables, we randomly selected 327 age, gender, and BMI matched euthyroid subjects as controls. All the subjects were free of NAFLD at baseline, and did not have a history of excessive alcohol consumption or liver disease. Subclinical hypothyroidism was defined as a TSH level of 4.5 mIU/L or greater, after excluding subjects with an abnormal thyroxine level [4Surks M.I. Ortiz E. Daniels G.H. Sawin C.T. Col N.F. Cobin R.H. et al.Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.JAMA. 2004; 291: 228-238Crossref PubMed Scopus (1546) Google Scholar, 5Rodondi N. Newman A.B. Vittinghoff E. de Rekeneire N. Satterfield S. Harris T.B. et al.Subclinical hypothyroidism and the risk of heart failure, other cardiovascularevents, and death.Arch Intern Med. 2005; 165: 2460-2466Crossref PubMed Scopus (410) Google Scholar]. NAFLD was diagnosed based on the results of abdominal ultrasonography, after exclusion of alcohol consumption, viral, or autoimmune liver disease [6Bedogni G. Miglioli L. Masutti F. Tiribelli C. Marchesini G. Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.Hepatology. 2005; 42: 44-52Crossref PubMed Scopus (1058) Google Scholar, 7Cerda C. Perez-Ayuso R.M. Riquelme A. Soza A. Villaseca P. Sir-Petermann T. et al.Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.J Hepatol. 2007; 47: 412-417Abstract Full Text Full Text PDF PubMed Scopus (170) Google Scholar]. The development of NAFLD was evaluated annually during follow-up by ultrasound examination, using a Toshiba Nemio 20 sonography machine with a 3.5-MHz probe (Toshiba, Tokyo, Japan). Ultrasound studies were carried out by experienced ultrasonographists who were blinded to the clinical and laboratory data. A total of 63 subclinical hypothyroidism subjects and 35 euthyroid subjects developed NAFLD during a median follow-up of 4.92 years. Compared to the euthyroid subjects, the incidence of NAFLD for 1000 person-years of follow-up was significantly higher in the subjects with subclinical hypothyroidism (38.3 vs. 21.8; p <0.05). Subclinical hypothyroidism subjects were further classified into three subgroups according to their TSH levels: 4.5–6.9 mIU/L (mild elevation), 7.0–9.9 mIU/L (moderate elevation), and 10.0 mIU/L or greater (severe elevation). The incidence of NAFLD showed an increased trend with increasing TSH levels. The incidence of NAFLD per 1000 person-years of follow-up was 21.8, 34.2, 48.3 and 52.5 for the euthyroid, mild, moderate and severe elevation subgroup, respectively (p <0.05 for trend). This observation indicated that subjects with higher baseline TSH levels are more likely to develop NAFLD during the follow-up period. Cox proportional hazards regression analyses were used to estimate hazard ratios for incident NAFLD for subclinical hypothyroidism over the follow-up period. Our analysis showed that subclinical hypothyro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503 · cited 2×
“5 mIU/L or greater, after excluding subjects with an abnormal thyroxine level [4,5].”
Background
Cited by
Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study
Bano, A., Chaker, L., Plompen, E. P. C., Hofman, A., Dehghan, A., Franco, O. H., Janssen, H. L. A., Murad, S. D., & Peeters, R. P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1300 · Cited by 209
“The only prospective study to date focused exclusively on the risk of NAFLD in subclinical hypothyroidism (15).”
BackgroundBreakthroughs in therapies for NASH and remaining challenges
Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132
Bruinstroop, E., Dalan, R., Cao, Y., Bee, Y. M., Chandran, K., Cho, L. W., Soh, S. B., Teo, E. K., Toh, S.-A., Leow, M. K. S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00475 · Cited by 108
NAFLD and thyroid function: pathophysiological and therapeutic considerations
Hatziagelaki, E., Paschou, S. A., Schön, M., Psaltopoulou, T., & Roden, M. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.08.001 · Cited by 93
“44), suggesting a causal relationship between impaired thyroid function NAFLD [21].”
Background
Metadata
- Authors
- Xu, L., Ma, H., Miao, M., & Li, Y.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 57
- Issue
- 5
- Pages
- 1153-1154
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2142324247
- Cited by
- 91
- References
- 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.